Overview
Sarah Baker practices practicing medicine in Edmonton, Canada.
Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Metastases, and Esophagitis.
She is actively involved in clinical research, co-authoring 36 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sarah E. Baker
Is Sarah E. Baker a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Sarah E. Baker is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sarah E. Baker participate in research or clinical trials?
Yes. Sarah E. Baker has published 36 articles and abstracts on conditions like Lung Cancer. You can view a list of Sarah E. Baker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EsophagitisMs. Baker isExperienced. Learn about Esophagitis.
- Lung CancerMs. Baker isExperienced. Learn about Lung Cancer.
- Lung MetastasesMs. Baker isExperienced. Learn about Lung Metastases.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Baker isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).